Related Experiment Video

Updated: Aug 17, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

16.0K

Plaque attack: Microglia have hard feelings toward amyloid-β

Harvey Davis1, David Attwell1

  • 1Department of Neuroscience, Physiology and Pharmacology, University College London, London, WC1E 6BT, UK.

Neuron
|January 5, 2023
PubMed

Insights

Microglia, immune cells in the brain, can sense and engulf amyloid-β plaques using a channel called Piezo1. This discovery offers new therapeutic strategies for Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia traditionally internalize amyloid-β (Aβ) through cell surface receptor binding.
  • Alzheimer's disease is characterized by the accumulation of Aβ plaques in the brain.

Purpose of the Study:

  • To investigate novel mechanisms by which microglia interact with and clear amyloid-β plaques.
  • To explore the role of mechanosensation in microglial phagocytosis of Aβ.

Main Methods:

  • Utilized advanced imaging techniques to observe microglial-plaque interactions.
  • Investigated the function of the Piezo1 channel in microglia during Aβ uptake.

Main Results:

  • Demonstrated that microglia utilize the stiffness-sensing channel Piezo1 to interact with Aβ plaques.
  • Showcased Piezo1-mediated mechanosensation as a key pathway for Aβ internalization by microglia.

Conclusions:

  • Microglial mechanosensing via Piezo1 is a critical mechanism for amyloid-β plaque clearance.
  • Targeting Piezo1 presents a potential new therapeutic avenue for Alzheimer's disease treatment.

More Related Videos

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques10:52

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Published on: June 1, 2016

11.5K
Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

8.5K

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...